> Among the antibodies showing neutralizing activity, one antibody stood out for its ability to completely block SARS-CoV-2 infection of healthy cells in the ex

> Among the antibodies showing neutralizing activity, one antibody stood out for its ability to completely block SARS-CoV-2 infection of healthy cells in the experiments. STI-1499 completely neutralized the virus infectivity at a very low antibody dose, making it a prime candidate for further testing and development. Initial biochemical and biophysical analyses also indicate STI-1499 is a potentially strong antibody drug candidate. https://investors.sorrentotherapeutics.com/node/11241/pdf https://investors.sorrentotherapeutics.com/node/11241/pdf This is as far from a "cure" or "treatment" as the Wright Brothers were from Apollo 11. In vitro results are a necessary, but insufficient path along the trajectory of developing a drug. Heck, this press release doesn't even mention in vivo experiments. Everything is on cells. Drug development is absolutely littered with the corpses of promising in vitro studies. Calling the experiments have have been run anything other than "preliminary work" is misleading.